The DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.
Mini‐review: Specificity and expression of CIITA, the master regulator of MHC class II genes
Open accessAbstract
The class II transactivator (CIITA) has been referred to as the "master control factor" for the expression of MHC class II (MHCII) genes. As our knowledge on the specificity and function of CIITA grows, it is becoming increasingly evident that this sobriquet is entirely justified. First, despite extensive investigations, the major target genes of CIITA remain those implicated in the presentation of antigenic peptides by MHCII molecules. Although other putative target genes have been reported, the contribution of CIITA to their expression remains indirect, controversial or comparatively minor relative to its decisive role as a regulator of MHCII and related genes. Second, the most important parameter dictating MHCII expression is by far the expression pattern of the gene encoding CIITA (MHC2TA). The vast majority of signals that activate or repress MHCII expression under physiological and pathological situations converge on one or more of the three alternative promoters that drive transcription of the MHC2TA gene. In short, with respect to its specificity and its exquisitely controlled pattern of expression, CIITA is by a long stretch the single most important transcription factor for the regulation of genes required for MHCII‐restricted antigen‐presentation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Projection of an Immunological Self Shadow Within the Thymus by the Aire Protein
Anderson, M. S., Venanzi, E. S., Klein, L., Chen, Z., Berzins, S. P., Turley, S. J., von Boehmer, H., Bronson, R., Dierich, A., Benoist, C., et al. (2002) · Science · doi:10.1126/science.1075958 · Cited by 2,486
Positive and negative selection of T cells
Starr, T. K., Jameson, S. C., & Hogquist, K. A. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141107 · Cited by 1,601
A new protein containing an SH2 domain that inhibits JAK kinases
Endo, T. A., Masuhara, M., Yokouchi, M., Suzuki, R., Sakamoto, H., Mitsui, K., Matsumoto, A., Tanimura, S., Ohtsubo, M., Misawa, H., et al. (1997) · Nature · doi:10.1038/43213 · Cited by 1,408
Statins as a newly recognized type of immunomodulator.
Kwak, B., Mulhaupt, F., Myit, S., & Mach, F. (2000) · Nature Medicine · doi:10.1038/82219 · Cited by 1,383
Youssef, S., Stüve, O., Patarroyo, J. C., Ruiz, P. J., Radosevich, J. L., Hur, E. M., Bravo, M., Mitchell, D. J., Sobel, R. A., Steinman, L., et al. (2002) · Nature · doi:10.1038/nature01158 · Cited by 1,097
Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology
Asselin-Paturel, C., Boonstra, A., Dalod, M., Durand, I., Yessaad, N., Dezutter-Dambuyant, C., Vicari, A., O'Garra, A., Biron, C., Brière, F., et al. (2001) · Nature Immunology · doi:10.1038/ni736 · Cited by 1,022
Regulation of MHC Class II Expression by Interferon-γ Mediated by the Transactivator Gene CIITA
Steimle, V., Siegrist, C.-A., Mottet, A., Lisowska-Grospierre, B., & Mach, B. (1994) · Science · doi:10.1126/science.8016643 · Cited by 898
Steimle, V (1993) · Cell · doi:10.1016/0092-8674(93)90685-j · Cited by 864
The molecular biology of the CCAAT-binding factor NF-Y
Mantovani, R. (1999) · Gene · doi:10.1016/s0378-1119(99)00368-6 · Cited by 861
Aire regulates negative selection of organ-specific T cells
Liston, A., Lesage, S., Wilson, J., Peltonen, L., & Goodnow, C. C. (2003) · Nature Immunology · doi:10.1038/ni906 · Cited by 807
Turner, C. A., Mack, D. H., & Davis, M. M. (1994) · Cell · doi:10.1016/0092-8674(94)90321-2 · Cited by 761
Yasukawa, H., Misawa, H., Sakamoto, H., Masuhara, M., Sasaki, A., Wakioka, T., Ohtsuka, S., Imaizumi, T., Matsuda, T., Ihle, J. N., et al. (1999) · The EMBO Journal · doi:10.1093/emboj/18.5.1309 · Cited by 719
Genetic Control of MHC Class II Expression
Ting, J. P.-Y., & Trowsdale, J. (2002) · Cell · doi:10.1016/s0092-8674(02)00696-7 · Cited by 584
The Bare Lymphocyte Syndrome and the Regulation of MHC Expression
Reith, W., & Mach, B. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.331 · Cited by 518
Self-citationMuhlethaler-Mottet, A. (1997) · The EMBO Journal · doi:10.1093/emboj/16.10.2851 · Cited by 507
Ko, H. S., Fu, S. M., Winchester, R. J., Yu, D. T., & Kunkel, H. G. (1979) · The Journal of experimental medicine · doi:10.1084/jem.150.2.246 · Cited by 439
A novel anti-inflammatory role for simvastatin in inflammatory arthritis.
Leung, B. P., Sattar, N., Crilly, A., Prach, M., McCarey, D. W., Payne, H., Madhok, R., Campbell, C., Gracie, J. A., Liew, F. Y., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.3.1524 · Cited by 434
Muhlethaler-Mottet, A., Di Berardino, W., Otten, L. A., & Mach, B. (1998) · Immunity · doi:10.1016/s1074-7613(00)80468-9 · Cited by 377
Self-citationMasternak, K., Muhlethaler-Mottet, A., Villard, J., Zufferey, M., Steimle, V., & Reith, W. (2000) · Genes & Development · doi:10.1101/gad.14.9.1156 · Cited by 355
Self-citationIdentification and characterization of a novel repressor of beta-interferon gene expression.
Keller, A. D., & Maniatis, T. (1991) · Genes & Development · doi:10.1101/gad.5.5.868 · Cited by 344
Steimle, V, Durand, B., Barras, E., Zufferey, M., Hadam, M. R., Mach, B., & Reith, W. (1995) · Genes & Development · doi:10.1101/gad.9.9.1021 · Cited by 338
Self-citationMiller, D. M., Rahill, B. M., Boss, J. M., Lairmore, M. D., Durbin, J. E., Waldman, J. W., & Sedmak, D. D. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.5.675 · Cited by 337
Activation of MHC Class I, II, and CD40 Gene Expression by Histone Deacetylase Inhibitors
Magner, W. J., Kazim, A. L., Stewart, C., Romano, M. A., Catalano, G., Grande, C., Keiser, N., Santaniello, F., & Tomasi, T. B. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.12.7017 · Cited by 294
Origin, precursors and differentiation of mouse dendritic cells
Ardavín, C. (2003) · Nature Reviews Immunology · doi:10.1038/nri1127 · Cited by 284
Masternak, K., Barras, E., Zufferey, M., Conrad, B., Corthals, G., Aebersold, R., Sanchez, J.-C., Hochstrasser, D. F., Mach, B., & Reith, W. (1998) · Nature Genetics · doi:10.1038/3081 · Cited by 276
Self-citationKanazawa, S., Okamoto, T., & Peterlin, B. M. (2000) · Immunity · doi:10.1016/s1074-7613(00)80159-4 · Cited by 262
Pai, R. K., Convery, M., Hamilton, T. A., Boom, W. H., & Harding, C. V. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.1.175 · Cited by 246
RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency
Durand, B. (1997) · The EMBO Journal · doi:10.1093/emboj/16.5.1045 · Cited by 227
Piskurich, J. F., Lin, K. I., Lin, Y., Wang, Y., Ting, J. P. Y., & Calame, K. (2000) · Nature Immunology · doi:10.1038/82788 · Cited by 215
Gobin, S. J. P., Peijnenburg, A., Keijsers, V., & van den Elsen, P. J. (1997) · Immunity · doi:10.1016/s1074-7613(00)80348-9 · Cited by 210
Induction of MHC Class I Expression by the MHC Class II Transactivator CIITA
Martin, B. K., Chin, K.-C., Olsen, J. C., Skinner, C. A., Dey, A., Ozato, K., & Ting, J. P.-Y. (1997) · Immunity · doi:10.1016/s1074-7613(00)80347-7 · Cited by 208
Zhong, G., Fan, T., & Liu, L. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.12.1931 · Cited by 196
Piskurich, J. F., Linhoff, M. W., Wang, Y., & Ting, J. P.-Y. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.431 · Cited by 187
CREB Regulates MHC Class II Expression in a CIITA-Dependent Manner
Moreno, C. S., Beresford, G. W., Louis-Plence, P., Morris, A. C., & Boss, J. M. (1999) · Immunity · doi:10.1016/s1074-7613(00)80015-1 · Cited by 184
Lee, Y. J., Han, Y., Lu, H. T., Nguyen, V, Qin, H., Howe, P. H., Hocevar, B. A., Boss, J. M., Ransohoff, R. M., & Benveniste, E. N. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.5.2065 · Cited by 177
Transcriptional regulation of antigen presentation
van den Elsen, P. J., Holling, T. M., Kuipers, H. F., & van der Stoep, N. (2004) · Current Opinion in Immunology · doi:10.1016/j.coi.2003.11.015 · Cited by 172
Nagarajan, U. M., Louis-Plence, P., DeSandro, A., Nilsen, R., Bushey, A., & Boss, J. M. (1999) · Immunity · doi:10.1016/s1074-7613(00)80016-3 · Cited by 166
Landmann, S., Mühlethaler-Mottet, A., Bernasconi, L., Suter, T., Waldburger, J.-M., Masternak, K., Arrighi, J.-F., Hauser, C., Fontana, A., & Reith, W. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.4.379 · Cited by 164
Self-citationTranscriptional regulation of the MHC class II antigen presentation pathway
Boss, J. M., & Jensen, P. E. (2003) · Current Opinion in Immunology · doi:10.1016/s0952-7915(02)00015-8 · Cited by 162
Piskurich, J. F., Wang, Y., Linhoff, M. W., White, L. C., & Ting, J. P. ‐. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.1.233 · Cited by 160
Silacci, P., Mühlethaler‐Mottet, A., Steimle, V., Reith, W., & Mach, B. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.180.4.1329 · Cited by 158
Self-citationO'Keefe, G. M., Nguyen, V. T., & Benveniste, E. N. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199904)29:04<1275::aid-immu1275>3.0.co;2-t · Cited by 157
Piskurich, J. F., Wang, Y., Linhoff, M. W., White, L. C., & Ting, J. P. ‐. (1998) · PubMed · Cited by 153
Holling, T. M., van der Stoep, N., Quinten, E., & van den Elsen, P. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.2.763 · Cited by 151
Modulation of Major Histocompatibility Class II Protein Expression by Varicella-Zoster Virus
Abendroth, A., Slobedman, B., Lee, E. Y., Mellins, E., Wallace, M. R., & Arvin, A. M. (2000) · Journal of Virology · doi:10.1128/jvi.74.4.1900-1907.2000 · Cited by 139
Immunologic mechanisms of antitumor activity
Foss, F. M. (2002) · Seminars in Oncology · doi:10.1053/sonc.2002.33076 · Cited by 136
CIITA-regulated plexin-A1 affects T-cell–dendritic cell interactions
Wong, A. W., Brickey, W. J., Taxman, D. J., van Deventer, H. W., REED, W. A., Gao, J. X., Zheng, P., Liu, Y., Li, P., Blum, J. S., et al. (2003) · Nature Immunology · doi:10.1038/ni960 · Cited by 135
Waldburger, J., Suter, T. B., Fontana, A., Acha‐Orbea, H., & Reith, W. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.4.393 · Cited by 132
Self-citationMorris, A. C., Beresford, G., Mooney, M. R., & Boss, J. M. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.13.4781-4791.2002 · Cited by 130
A transcriptional repressor of c-myc
Kakkis, E., Riggs, K. J., Gillespie, W., et al. (1989) · Nature · doi:10.1038/339718a0 · Cited by 125
TGF-beta attenuates the class II transactivator and reveals an accessory pathway of IFN-γ action
Nandan, D., & Reiner, N. E. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.3.1095 · Cited by 121
Toes, R. E. M., Schoenberger, S. P., van der Voort, E. I. H., Offringa, R., & Melief, C. J. M. (1998) · Seminars in Immunology · doi:10.1006/smim.1998.0147 · Cited by 117
Wojciechowski, W., Sanctis, J. B. D., Skamene, E., & Radzioch, D. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.5.2688 · Cited by 109
Regulation of Class II MHC Expression in APCs: Roles of Types I, III, and IV Class II Transactivator
Pai, R. K., Askew, D. S., Boom, W. H., & Harding, C. V. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.3.1326 · Cited by 107
Sisk, T. J., Gourley, T. S., Roys, S., & Chang, C. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.5.2511 · Cited by 106
O'Keefe, G. M., Nguyen, V. T., Tang, L. P., & Benveniste, E. N. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.4.2260 · Cited by 103
Viral inhibition of MHC class II antigen presentation
Hegde, N. R. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(03)00099-1 · Cited by 101
Methylation of Class II trans-Activator Promoter IV: A Novel Mechanism of MHC Class II Gene Control
Morris, A. C., Spangler, W. E., & Boss, J. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.8.4143 · Cited by 95
Lüder, C. G. K., Lang, C., Giraldo‐Velásquez, M., Algner, M., Gerdes, J., & Groß, U. (2003) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00320-x · Cited by 94
Importance of CD4+ T helper cell responses in tumor immunity
OSSENDORP, F. A., Toes, R. E. M., Offringa, R., van der Burg, S. H., & Melief, C. J. M. (2000) · Immunology Letters · doi:10.1016/s0165-2478(00)00252-2 · Cited by 92
IFN-gamma regulation of the type IV class II transactivator promoter in astrocytes.
Dong, Y., Rohn, W. M., & Benveniste, E. N. (1999) · PubMed · Cited by 89
Modulation of Gene Expression by the MHC Class II Transactivator
Nagarajan, U. M., Long, A. B., & Boss, J. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.9.5078 · Cited by 87
Roy, E. L., Mühlethaler‐Mottet, A., Davrinche, C., Mach, B., & Davignon, J. (1999) · Journal of Virology · doi:10.1128/jvi.73.8.6582-6589.1999 · Cited by 82
Isolation of a B-cell-specific promoter for the human class II transactivator
Lennon, A., Ottone, C., Rigaud, G., Deaven, L. L., Longmire, J., Fellous, M., Bono, R., & Alcaïde‐Loridan, C. (1997) · Immunogenetics · doi:10.1007/s002510050202 · Cited by 81
Gourley, T. S., Roys, S., Lukacs, N. W., Kunkel, S. L., Flavell, R. A., & Chang, C. (1999) · Immunity · doi:10.1016/s1074-7613(00)80037-0 · Cited by 79
Dong, Y., Tang, L., Letterio, J. J., & Benveniste, E. N. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.1.311 · Cited by 77
IFN-γ Regulation of the Type IV Class II Transactivator Promoter in Astrocytes
Dong, Y., Rohn, W. M., & Benveniste, E. N. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.8.4731 · Cited by 75
Regulation of MHC class II expression in human T-cell malignancies
Holling, T. M., Schooten, E., Langerak, A. W., et al. (2003) · Blood · doi:10.1182/blood-2003-05-1491 · Cited by 74
CIITA activates the expression of MHC class II genes in mouse T cells
Chang, C., Hong, S., Hughes, C. C. W., Janeway, C. A., & Flavell, R. A. (1995) · International Immunology · doi:10.1093/intimm/7.9.1515 · Cited by 74
Deffrennes, V., Vedrenne, J., Stolzenberg, M., Piskurich, J. F., Barbieri, G., Ting, J. P. ‐., Charron, D. J., & Alcaïde‐Loridan, C. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.1.98 · Cited by 72
van den Elsen, P. J., van der Stoep, N., Viëtor, H. E., Wilson, L., van Zutphen, M., & Gobin, S. J. P. (2000) · Human Immunology · doi:10.1016/s0198-8859(00)00159-2 · Cited by 72
Zhu, X., & Ting, J. P. ‐. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.20.7078-7088.2001 · Cited by 69
Ghosh, N., Győry, I., Wright, G. M., Wood, J., & Wright, K. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100862200 · Cited by 68
Gourley, T. S., & Chang, C. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.5.2917 · Cited by 67
Murphy, S. P., & Tomasi, T. B. (1998) · Molecular Reproduction and Development · doi:10.1002/(sici)1098-2795(199809)51:1<1::aid-mrd1>3.0.co;2-l · Cited by 67
van der Stoep, N., Biesta, P. J., Quinten, E., & van den Elsen, P. J. (2001) · International Journal of Cancer · doi:10.1002/ijc.1623 · Cited by 66
The RFX Family Interacts at the Collagen (COL1A2) Start Site and Represses Transcription
Sengupta, P. K., Fargo, J. H., & Smith, B. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111712200 · Cited by 63
Jabrane‐Ferrat, N., Fontes, J. D., Boss, J. M., & Peterlin, B. M. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4683 · Cited by 58
Nikcevich, K. M., Piskurich, J. F., Hellendall, R. P., Wang, Y., & Ting, J. P. ‐. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00117-4 · Cited by 54
Ghosh, N., Piskurich, J. F., Wright, G. M., Hassani, K., Ting, J. P. ‐., & Wright, K. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32342 · Cited by 54
Regulation and Specificity of MHC2TA Promoter Usage in Human Primary T Lymphocytes and Cell Line
Wong, A. W., Ghosh, N., McKinnon, K. P., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.6.3112 · Cited by 53
Tumour immunology, vaccination and escape strategies
Garcia-Lora, A. M., Algarra, I., Collado, A., & Garrido, F. (2003) · European Journal of Immunogenetics · doi:10.1046/j.1365-2370.2003.00384.x · Cited by 53
van den Elsen, P. J., Holling, T. M., van der Stoep, N., & Boss, J. M. (2003) · Clinical Immunology · doi:10.1016/s1521-6616(03)00200-6 · Cited by 51
Taxman, D. J., Cressman, D. E., & Ting, J. P. ‐. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.3.1410 · Cited by 50
Koivisto, P. A., & Rantala, I. S. (1999) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199901)187:2<191::aid-path206>3.0.co;2-3 · Cited by 49
MHC Class II Gene Silencing in Trophoblast Cells Is Caused by Inhibition of CIITA Expression
Morris, A. C., Riley, J. L., Fleming, W., & Boss, J. M. (1998) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.1998.tb00423.x · Cited by 48
van der Stoep, N., Quinten, E., & van den Elsen, P. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.9.5061 · Cited by 47
Kanaseki, T., Ikeda, H., Takamura, Y., Toyota, M., Hirohashi, Y., Tokino, T., Himi, T., & Sato, N. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.10.4980 · Cited by 44
Rohn, W. M., Tang, L. P., Dong, Y., & Benveniste, E. N. (1999) · PubMed · Cited by 43
Class II Transactivator Is Required for Maximal Expression of HLA-DOB in B Cells
Nagarajan, U. M., Lochamy, J., Chen, X., Beresford, G., Nilsen, R., Jensen, P. E., & Boss, J. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.4.1780 · Cited by 42
Rohn, W. M., Tang, L. P., Dong, Y., & Benveniste, E. N. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.2.886 · Cited by 39
Promoter IV of the class II transactivator gene is essential for positive selection of CD4+ T cells
Waldburger, J., Rossi, S. W., Holländer, G. A., Rodewald, H.-R., Reith, W., & Acha‐Orbea, H. (2003) · Blood · doi:10.1182/blood-2002-06-1855 · Cited by 38
Self-citationGoodwin, B. L., Huang, X., Tejiram, R., Eason, D. D., Ghosh, N., Wright, K. L., Nagarajan, U. M., Boss, J. M., & Blanck, G. (2001) · PubMed · Cited by 38
Deregulated MHC Class II Transactivator Expression Leads to a Strong Th2 Bias in CD4+ T Lymphocytes
Otten, L., Tacchini‐Cottier, F., Lohoff, M. D., Annunziato, F., Cosmi, L., Scarpellino, L., Louis, J. A., Steimle, V., Reith, W., & Acha‐Orbea, H. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.3.1150 · Cited by 36
Self-citationAberrant Expression of Fas Ligand in Mice Deficient for the MHC Class II Transactivator
Gourley, T. S., Patel, D. R., Nickerson, K. M., Hong, S., & Chang, C. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4414 · Cited by 36
Miller, D. M., Cebulla, C. M., & Sedmak, D. D. (2002) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-59421-2_10 · Cited by 33
Sartoris, S., Tosi, G., Barbaro, A. D. L., Cestari, T., & Accolla, R. S. (1996) · European Journal of Immunology · doi:10.1002/eji.1830261028 · Cited by 30
T cell-mediated immune responses in melanoma: implications for immunotherapy
Wang, R., Zeng, G., Johnston, S. F., Voo, K., & Ying, H. (2002) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(01)00186-x · Cited by 30
Croce, M., Ambrosis, A. D., Corrias, M. V., Pistoia, V., Occhino, M., Meazza, R., Giron‐Michel, J., Azzarone, B. G., Accolla, R. S., & Ferrini, S. (2003) · Oncogene · doi:10.1038/sj.onc.1207054 · Cited by 29
Geirsson, A., Paliwal, I., Lynch, R., Bothwell, A. L. M., & Hammond, G. L. (2003) · Transplantation · doi:10.1097/01.tp.0000073612.04525.46 · Cited by 28
Murphy, S. P., Holtz, R., Lewandowski, N. M., Tomasi, T. B., & Fuji, H. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.6.3085 · Cited by 27
Class II transactivator‐induced expression of HLA‐DOβ in HeLa cells
Khalil, H., Deshaies, F., Bellemare‐Pelletier, A., Brunet, A., Faubert, A., Azar, G. A., & Thibodeau, J. (2002) · Tissue Antigens · doi:10.1034/j.1399-0039.2002.600504.x · Cited by 25
Gao, J., De, B. P., Han, Y., Choudhary, S. K., Ransohoff, R. M., & Banerjee, A. K. (2001) · Journal of Virology · doi:10.1128/jvi.75.3.1124-1131.2001 · Cited by 20
Santos, A. N. (1998) · International Immunology · doi:10.1093/intimm/10.5.601 · Cited by 19
Kielar, M. L., Sicher, S. C., Penfield, J. G., Jeyarajah, D. R., & Lu, C. Y. (2000) · Inflammation · doi:10.1023/a:1007012128392 · Cited by 19
Isoforms of the class II transactivator protein
Barbieri, G. (2002) · International Immunology · doi:10.1093/intimm/dxf060 · Cited by 17
MHC class II‐deficient tumor cell lines with a defective expression of the class II transactivator
Naves, R. F., Lennon, A. M., Barbieri, G., Reyes, L. I., Yung, G. P., Salas‐Cortés, L., Deffrennes, V., Rosemblatt, M. S., Fellous, M., Charron, D. J., et al. (2002) · International Immunology · doi:10.1093/intimm/14.5.481 · Cited by 9
Bischof, A. (2000) · doi:10.1002/1521-4141(200003)30:3
Cited by
Interferons at age 50: past, current and future impact on biomedicine
Borden, E. C., Sen, G. C., Uze, G., Silverman, R. H., Ransohoff, R. M., Foster, G. R., & Stark, G. R. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2422 · Cited by 1,154
Nod-like proteins in immunity, inflammation and disease
Fritz, J. H., Ferrero, R. L., Philpott, D. J., & Girardin, S. E. (2006) · Nature Immunology · doi:10.1038/ni1412 · Cited by 892
NLRs join TLRs as innate sensors of pathogens
MARTINON, F., & TSCHOPP, J. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.06.004 · Cited by 673
Engineered Virus-like Particles for Efficient in Vivo Delivery of Therapeutic Proteins
Banskota, S., Raguram, A., Suh, S., Du, S. W., Davis, J. R., Choi, E. H., Wang, X., Nielsen, S. C., Newby, G. A., Randolph, P. B., et al. (2022) · Cell · doi:10.1016/j.cell.2021.12.021 · Cited by 668
Schlitzer, A., Sivakamasundari, V, Chen, J., Sumatoh, H. R. B., Schreuder, J., Lum, J., Malleret, B., Zhang, S., Larbi, A., Zolezzi, F., et al. (2015) · Nature Immunology · doi:10.1038/ni.3200 · Cited by 574
Metadata
- Authors
- LeibundGut‐Landmann, S., Waldburger, J., Krawczyk, M., Otten, L. A., Suter, T., Fontana, A., Acha‐Orbea, H., & Reith, W.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 2004-05-18
- Volume
- 34
- Issue
- 6
- Pages
- 1513-1525
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W1963848341
- Cited by
- 277
- References
- 108
- FWCI
- 6.34
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.